✦ LIBER ✦

Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001

✍ Scribed by Roberto H. Nussenzveig; Jorge Cortes; Matjaz Sever; Alfonso Quintás-Cardama; Pat Ault; Taghi Manshouri; Carlos Bueso-Ramos; Josef T. Prchal; Hagop Kantarjian; Srdan Verstovsek

Book ID: 107618796
Publisher: Carden Jennings Publishing
Year: 2009
Tongue: English
Weight: 230 KB
Volume: 90
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-009-0345-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon α therapy for patients with e

Interferon α therapy for patients with essential thrombocythemia : Final results of a phase II study initiated in 1986

✍ Rashid Saba; Elias Jabbour; Francis Giles; Jorge Cortes; Moshe Talpaz; Susan O'B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Vatalanib for metastatic gastrointestina

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

✍ Joensuu, H; De Braud, F; Grignagni, G; De Pas, T; Spitalieri, G; Coco, P; Spreaf 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 253 KB

Efficacy and Safety of Imatinib Mesylate

Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia: Results of a Japanese Phase II Clinical Study

✍ Yasuo Morishima; Michinori Ogura; Miki Nishimura; Fumiharu Yazaki; Masami Bessho 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 93 KB

Combination Therapy of Imatinib Mesylate

Combination Therapy of Imatinib Mesylate and Interferon-α Demonstrates Minimal Activity and Significant Toxicity in Metastatic Renal Cell Carcinoma: Results of a Single-Institution Phase II Trial

✍ Blase N. Polite; Apurva A. Desai; Beth Manchen; Walter M. Stadler 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 502 KB

866 POSTER A phase II study of intravesi

866 POSTER A phase II study of intravesical gemcitabine as adjuvant therapy in patients (pts) with superficial bladder carcinoma: final results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Final results of a phase II study ofnab-

Final results of a phase II study ofnab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB